Valentin, G., Friis, K., Nielsen, C. P., Larsen, F. B. & Langdahl, B. L. (2021).
Fragility fractures and health-related quality of life: does socio-economic status widen the gap? A population-based study.
Osteoporosis International,
32(1), 63-73.
https://doi.org/10.1007/s00198-020-05540-8
Valentin, G., Ravn, M. B., Jensen, E. K., Friis, K., Bhimjiyani, A., Ben-Shlomo, Y., Hartley, A.
, Nielsen, C. P., Langdahl, B. & Gregson, C. L. (2021).
Socio-economic inequalities in fragility fracture incidence: A systematic review and meta-analysis of 61 observational studies.
Osteoporosis International,
32(12), 2433-2448.
https://doi.org/10.1007/s00198-021-06038-7
Vestergaard, E. T., Zubanovic, N. B., Rittig, N., Moller, N., Kuhre, R. E., Holst, J. J., Rehfeld, J. F.
& Thomsen, H. H. (2021).
Acute ketosis inhibits appetite and decreases plasma concentrations of acyl ghrelin in healthy young men.
Diabetes, Obesity and Metabolism,
23(8), 1834-1842.
https://doi.org/10.1111/dom.14402
Vistisen, D., Andersen, G. S.
, Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E.
, Thomsen, R. W., Persson, F., Rossing, P. & Jørgensen, M. E. (2021).
A validated prediction model for end-stage kidney disease in type 1 diabetes.
Diabetes Care,
44(4), 901-907.
https://doi.org/10.2337/dc20-2586Vistisen, D., Andersen, G. S.
, Hulman, A., McGurnaghan, S. J., Colhoun, H. M., Henriksen, J. E.
, Thomsen, R. W., Persson, F.
, Rossing, P. & Jørgensen, M. E. (2021).
Response to Comment on Vistisen et al. A validated prediction model for endstage kidney disease in type 1 diabetes. Diabetes care 2021;44:901–907.
Diabetes Care,
44(6), e140-e141.
https://doi.org/10.2337/dci21-0010Viuff, M. H., Stochholm, K., Lin, A.
, Berglund, A., Juul, S. & Gravholt, C. H. (2021).
Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy.
European Journal of Endocrinology,
184(1), 79-88.
https://doi.org/10.1530/EJE-20-0702
Viuff, M. H., Stochholm, K., Grønbaek, H., Berglund, A., Juul, S. & Gravholt, C. H. (2021).
Increased occurrence of liver and gastrointestinal diseases and anaemia in women with Turner syndrome - a nationwide cohort study.
Alimentary Pharmacology and Therapeutics,
53(7), 821-829.
https://doi.org/10.1111/apt.16277
von Herrath, M., Bain, S. C., Bode, B., Clausen, J. O., Coppieters, K., Gaysina, L., Gumprecht, J.
, Hansen, T. K., Mathieu, C., Morales, C., Mosenzon, O., Segel, S., Tsoukas, G., Pieber, T. R. & Anti-IL-21–liraglutide Study Group investigators and contributors (2021).
Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial.
The Lancet Diabetes & Endocrinology,
9(4), 212-224.
https://doi.org/10.1016/S2213-8587(21)00019-XWinkel, P., Hilden, J., Jakobsen, J. C., Lindschou, J., Jensen, G. B., Kjøller, E., Sajadieh, A., Kastrup, J., Kolmos, H. J., Larsson, A., Ärnlöv, J.
, Bjerre, M. & Gluud, C. (2021).
A screening method to spot biomarkers that may warn of serious events in a chronic disease - illustrated by cardiological CLARICOR trial data.
Clinical Chemistry and Laboratory Medicine,
59(11), 1852-1860.
https://doi.org/10.1515/cclm-2021-0333